Pan-Viral ACTIONS
A Call to Implement One-stop Screening
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.
Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: an interrupted time series analysis.
Bartholomew TS, Tookes HE, Serota DP, et al. Int J Drug Policy. 2020;84:102875.
Addressing barriers to on-site HIV and HCV testing services in methadone maintenance treatment programs in the United States: findings from a national multisite qualitative study.
Behrends CN, Kapadia SN, Schackman BR, et al. J Public Health Manag Pract. 2021;27(4):393-402.
Improving HIV and HCV Testing in Substance Use Disorder Programs (SUDs) That Provide Medications for Opiate Use Disorder (MOUD): Role of Addressing Barriers and Implementing Universal and Site-Specific Approaches.
Brooks R, Wegener M, Freeman B, et al. Health Promot Pract. 2023;24(5):1018-1028.
Issue brief: status neutral HIV care and service delivery.
CDC.
Bundling rapid human immunodeficiency virus and hepatitis c virus testing to increase receipt of test results: a randomized trial.
Frimpong JA, Shiu-Yee K, Tross S, et al. Med Care. 2020;58(5):445-452.
Adoption of electronic health record among substance use disorder treatment programs: nationwide cross-sectional survey study.
Frimpong JA, Liu X, Liu L, et al. J Med Internet Res. 2023;25:e45238.
CLINICAL PRACTICE GUIDELINES
When and in whom to initiate HCV therapy
American Association for the Study of Liver Diseases and Infectious Diseases Society of America.
STI and HIV infection risk assessment.
Centers for Disease Control and Prevention (CDC).
Screening and testing for hepatitis B virus infection: CDC recommendations - United States, 2023.
Conners EE, Panagiotakopoulos L, Hofmeister MG, et al. MMWR Recomm Rep. 2023;72(1):1-25.
WHO 2024 hepatitis B guidelines: an opportunity to transform care.
Easterbrook PJ, Luhmann N, Bajis S, et al. Lancet Gastroenterol Hepatol. 2024;9(6):493-495.
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA Panel.
Gandhi RT, Bedimo R, Hoy JF, et al. JAMA. 2023;329(1):63-84.
CDC recommendations for hepatitis C screening among adults - United States, 2020.
Schillie S, Wester C, Osborne M, et al. MMWR Recomm Rep. 2020;69(2):1-17.
Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV.
US Department of Health and Human Services.
Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update). A clinical practice guideline.
US Public Health Service. Centers for Disease Control and Prevention; 2021.
Final Recommendation Statement. Prevention of Acquisition of HIV: Preexposure Prophylaxis.
U.S. Preventive Services Task Force. 2023.
CLINICIAN RESOURCES
Hepatitis B vaccine.
CDC.
National Clinician Consultation Center.
University of California, San Francisco.
US Preventive Services Task Force.
Published recommendations.
